These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34120432)

  • 21. Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy.
    Li YS; Jiang BY; Yang JJ; Zhang XC; Zhang Z; Ye JY; Zhong WZ; Tu HY; Chen HJ; Wang Z; Xu CR; Wang BC; Du HJ; Chuai S; Han-Zhang H; Su J; Zhou Q; Yang XN; Guo WB; Yan HH; Liu YH; Yan LX; Huang B; Zheng MM; Wu YL
    Ann Oncol; 2018 Apr; 29(4):945-952. PubMed ID: 29346604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik PA; Glantz MJ
    Neuro Oncol; 2001 Jan; 3(1):42-5. PubMed ID: 11305416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Advances in Diagnosis and Treatment of Leptomeningeal Metastasis of Lung Cancer].
    Gao N; Xin T
    Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):517-523. PubMed ID: 35899451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment using targeted therapy, radiotherapy, and intrathecal chemotherapy in a patient with leptomeningeal metastasis with an epidermal growth factor receptor exon 20 insertion mutation: a case report.
    Ma Y; Liu H; Zhang M; Liu B; Ding Q; Zhang L; Guo L; Liu M
    Ann Palliat Med; 2022 Apr; 11(4):1533-1541. PubMed ID: 34263612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and quantification of CSF malignant cells by the CellSearch technology in patients with melanoma leptomeningeal metastasis.
    Le Rhun E; Tu Q; De Carvalho Bittencourt M; Farre I; Mortier L; Cai H; Kohler C; Faure GC
    Med Oncol; 2013 Jun; 30(2):538. PubMed ID: 23504338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel method for the detection and quantification of malignant cells in the CSF of patients with leptomeningeal metastasis of lung cancer.
    Ma C; Lv Y; Jiang R; Li J; Wang B; Sun L
    Oncol Lett; 2016 Jan; 11(1):619-623. PubMed ID: 26870256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid-dissemination of a ovarian clear cell carcinoma: A leptomeningial carcinomatosis with diagnostic challenges.
    Koyuncuer A; Varol E; Serarslan Yağcioğlu B; Bükte Y; Sakcı Z
    Diagn Cytopathol; 2023 Aug; 51(8):E228-E231. PubMed ID: 37071049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.
    Zhao Y; He JY; Zou YL; Guo XS; Cui JZ; Guo L; Bu H
    BMC Neurol; 2019 Dec; 19(1):331. PubMed ID: 31856745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis.
    Straathof CS; de Bruin HG; Dippel DW; Vecht CJ
    J Neurol; 1999 Sep; 246(9):810-4. PubMed ID: 10525979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing discrepancy of MR imaging and CSF study in patients with leptomeningeal seeding from lung adenocarcinoma after targeted therapy using a tyrosine kinase inhibitor.
    Seong M; Park S; Kim ST; Goo Park S; Kim Y; Cha J; Yeop Kim E; Kim HJ; Ahn MJ
    Medicine (Baltimore); 2023 Oct; 102(40):e35387. PubMed ID: 37800766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential ALK inhibitor treatment benefits patient with leptomeningeal metastasis harboring non-EML4-ALK rearrangements detected from cerebrospinal fluid: A case report.
    Li Z; Li P; Yan B; Gao Q; Jiang X; Zhan Z; Yan Q; Lizaso A; Huang C
    Thorac Cancer; 2020 Jan; 11(1):176-180. PubMed ID: 31766077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay.
    Wooster M; McGuinness JE; Fenn KM; Singh VM; Franks LE; Lee S; Cieremans D; Lassman AB; Hershman DL; Crew KD; Accordino MK; Trivedi MS; Iwamoto F; Welch MR; Haggiagi A; Schultz RD; Huynh L; Sales E; Fisher D; Mayer JA; Kreisl T; Kalinsky K
    Clin Breast Cancer; 2022 Jun; 22(4):e457-e462. PubMed ID: 34920954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases.
    Brandsma D; Voest EE; de Jager W; Bonfrer H; Algra A; Boogerd W; Korse T; Reijneveld JC; Verbeek MM; Rijkers G; Taphoorn MJ
    J Neurol; 2006 Sep; 253(9):1177-84. PubMed ID: 16998648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma.
    Huang S; Kang X; Wang C; Zhang W; Jiang J; Kang Z; Yang S; Chen J; Chen F; Li W
    J Cancer Res Ther; 2024 Apr; 20(2):658-664. PubMed ID: 38687937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid cytology diagnosis of meningeal carcinomatosis in patients with small-cell carcinoma of the lung. A study of interobserver and intraobserver variability.
    Pedersen AG; Olsen J; Nasiell M
    Acta Cytol; 1986; 30(6):648-52. PubMed ID: 3024430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
    van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
    Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
    Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
    J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study.
    Zhou T; Zhu S; Xiong Q; Gan J; Wei J; Cai J; Liu A
    BMC Cancer; 2023 Apr; 23(1):333. PubMed ID: 37041504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases.
    Diaz M; Singh P; Kotchetkov IS; Skakodub A; Meng A; Tamer C; Young RJ; Reiner AS; Panageas KS; Ramanathan LV; Pentsova E
    J Neurooncol; 2022 Mar; 157(1):81-90. PubMed ID: 35113288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.